Streetbeat News

Stock Prices

VRT

Vertiv Holdings Co (VRT) has projected its Q4 FY23 sales to be between $1.828B and $1.853B, surpassing the consensus estimate of $1.82B. The company also expects its adjusted EPS to be between $0.48 and $0.52, higher than the consensus estimate of $0.47.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:59 am

VRT

Vertiv Hldgs (NYSE:VRT) reported Q3 adjusted earnings of $0.52 per share, beating the analyst consensus estimate of $0.44 by 18.18%. This is a 126.09% increase from the same period last year. However, the company's quarterly sales of $1.74 billion missed the analyst consensus estimate of $1.75 billion by 0.40%, though it's a 17.69% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:57 am

ATEC

CSGP

GOOGL

IBRX

IDYA

SPWR

TDOC

TXN

VICR

Several US stocks recorded losses in Wednesday's pre-market trading session. Vicor Corporation, Alphatec Holdings, IDEAYA Biosciences, SunPower Corporation, CoStar Group, ImmunityBio, Teladoc Health, Alphabet Inc., and Texas Instruments Incorporated all saw their shares decline. The reasons for the declines varied, with some companies reporting worse-than-expected sales results, others pricing public offerings, and some restating financial statements.

Portfolio Pulse from Lisa Levin

October 25, 2023 | 9:49 am

LHX

LMT

NOC

RTX

CNBC host Jim Cramer suggests investing in defense stocks as the U.S. plans to rebuild its arsenal capacity. He believes that defense companies like Lockheed Martin, Raytheon, Boeing, Northrop Grumman, General Dynamics, and L3Harris Technologies present worthy investment opportunities. Cramer also highlighted L3Harris Technologies as potentially the best investment due to its acquisition of Aerojet Rocketdyne.

Portfolio Pulse from Benzinga Neuro

October 25, 2023 | 9:48 am

MMTOF

NSANY

The top-selling electric vehicle (EV) in Japan is the Sakura, a kei car co-developed by Nissan Motor Co. (OTC:NSANY) and Mitsubishi Motors Corp. (OTC:MMTOF). The Sakura and its Mitsubishi counterpart, the eK X, account for nearly half of all EV sales in Japan this year. Despite the overall subdued EV market in Japan, these models have found favor with consumers for their affordability and practicality. However, success in Japan doesn’t translate into overseas sales due to stricter collision standards and regulations in other countries.

Portfolio Pulse from Benzinga Neuro

October 25, 2023 | 9:36 am

BIVI

BioVie is set to present blinded data on NE3107, a treatment for mild to moderate Alzheimer's disease, at the Clinical Trials on Alzheimer's Disease (CTAD) conference. The company's shares are up 31% in premarket trading.

Portfolio Pulse from Charles Gross

October 25, 2023 | 9:25 am

GPI

Group 1 Automotive (NYSE:GPI) reported Q3 adjusted earnings of $12.07 per share, beating the analyst consensus estimate of $11.48 by 5.14%. This is a 0.58% increase from the same period last year. The company also reported quarterly sales of $4.71 billion, surpassing the analyst consensus estimate of $4.51 billion by 4.32%, a 13.02% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:07 am

UMC

United Microelectronics (NYSE:UMC) reported Q3 earnings of $0.20 per share, beating the analyst consensus estimate of $0.17 by 17.65%. However, this is a 42.03% decrease from the same period last year. The company also reported quarterly sales of $1.77 billion, beating the estimate of $1.75 billion by 1.14%, but this is a 25.63% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:03 am

MOR

MorphoSys has updated its 2023 Monjuvi US net product sales forecast to $85M-$95M, a slight increase from the previous estimate of $80M-$95M. The gross margin for Monjuvi US net product sales is expected to be around 75%, a slight decrease from the previous range of 75%-80%.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 9:00 am

TRU

B of A Securities analyst Heather Balsky has downgraded TransUnion (NYSE:TRU) from Buy to Underperform and lowered the price target from $95 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 8:55 am